Adapted FOY+ImPACT for Adolescent Behaviors

Phase-Based Progress Estimates
Adolescent Behaviors+3 More
Adapted FOY+ImPACT - Behavioral
< 18
All Sexes
What conditions do you have?

Study Summary

This trial is looking at a way to use libraries to help prevent substance abuse and sexual risk taking among urban African American adolescents who have parents that abuse drugs.

Eligible Conditions
  • Adolescent Behaviors
  • Substance Use
  • Sexual Behaviour

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: baseline, post intervention and 3 months

Month 3
2. Change in youth sexual risk-taking based on Youth Risk Behavior Surveillance Survey
Change in youth substance use based on Youth Risk Behavior Surveillance Survey

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: Adapted FOY+ImPACT · No Placebo Group · N/A

Experimental Group · 1 Intervention: Adapted FOY+ImPACT · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post intervention and 3 months

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
365 Previous Clinical Trials
1,943,603 Total Patients Enrolled
3 Trials studying Adolescent Behaviors
1,669 Patients Enrolled for Adolescent Behaviors
Terrinieka Powell, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: November 27th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.